Market Report: Worldwide worries weigh on blue chips

If you were one of the punters who asked recently if the benchmark index could manage to reach 6,000 again, then the answer is – not any time soon. After a lacklustre summer, traders had hoped the autumn could be better. But yesterday, the FTSE 100 posted its biggest one-day drop in almost a month, wiping out last week's gains.

The index sunk 85 points to 5,797.91, dragged down by renewed eurozone crisis concerns, weak US earnings and caution ahead of today's Chinese manufacturing index figures.

The only chink of light on the blue-chip index was Cambridge star ARM Holdings. The company which makes chip processors for a variety of gadgets, including Apple's iPhones and iPads, revealed its pre-tax profits had jumped 28 per cent to £68.1m for the three months to October. Its shares computed a 45.5p gain to 640p, taking it to the top of the leaderboard.

And ARM could be in for a further boost – it gets a royalty payment every time Apple sells a gizmo created with its technology, so last night's launch of the mini-iPad may help it higher.

Talking of microchip makers from Cambridge, investors in CSR were counting their chips after news that its deal to sell its mobile handset business to Samsung will bring a special payout their way.

If you are not already an investor, analysts reckon it is still a good time to invest. Liberum Capital kept its buy rating on the shares and issued a share price target of 400p. It thinks the group has "transformed after the sale of its handset business" and "no longer deserves to trade at a discount to peers".

The wireless technology specialist confirmed the completion of the sale to South Korea's Samsung in its third-quarter results. The deal leaves Samsung with a 4.9 per cent stake in the company. Details of the $285m (£178m) tender offer to shareholders will be confirmed next quarter.

CSR's profits soared to $32.2m, up from $24.3m in the same period last year but its shares lost 6.2p to 332.5p despite a spike earlier in the day.

The doom and gloom and the lacklustre performance of the markets meant traders had time for some gossip. But the only market chatter doing the rounds appeared to be vague speculation in the pharmaceutical sector that a purchase could be on the cards for AstraZeneca with rumours that rival GlaxoSmithKline might also be interested. But the chat failed to excite the share price and its shares lost 38p to 2,900p.

The only "real" news in the sector came in the shape of AstraZeneca's tie-up with US drug maker Ironwood to make irritable bowel syndrome drugs for China.

Anglo-Dutch oil group Shell warned yesterday that it won't be able to make its estimated production for two types of oil pumped from Nigeria, blaming attacks on its pipelines by thieves. Its shares slipped 30p to 2,172.5p.

Journalists and scandal go hand in hand. This time, phone-hacking allegations have knocked more than 10 per cent off the share price of the owner of the Daily Mirror.

A lawyer has lodged legal claims for four people – including former England football manager Sven-Goran Eriksson – accusing the group's newspapers of hacking into phones to get stories. As a result, Shares in Trinity Mirror lost 7.25p to 64.5p. The case is yet another problem for new chief executive Simon Fox.

On Monday, Investec's Ian Gordon said flog Royal Bank of Scotland shares: yesterday it was Lloyds Banking Group that displeased him. He points out that falling Dutch house prices are bad news for the bank. He gave it a share price target of 36p and claims Lloyds' "Dutch exposure is a drag on its (generally improving) bad debt story". Lloyds lost 0.52p to 40.3p.

Watchers of the luxury sector were spooked by another profit warning. This time, AIM-listed handbag brand Mulberry revealed profits won't be as high as hoped as its decision to go more upmarket has hit sales. The company's shares tumbled nearly 24 per cent, losing 314p to 1,006p.

Upmarket brand Burberry was hit by the news – and fears of the outcome from the Chinese manufacturing survey tomorrow – and it sank 38p to 1,134p. The sector will now be looking to Gucci and Stella McCartney-owner PPR's third-quarter results tomorrow for any further indications on the outlook for luxury.

Start your day with The Independent, sign up for daily news emails
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Digital Optimisation Executive - Marketing

£30000 - £35000 per annum: Recruitment Genius: The UK's fastest growing, multi...

Recruitment Genius: Financial Reporting Manager

£70000 - £90000 per annum: Recruitment Genius: A Financial Reporting Manager i...

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Day In a Page

Syria civil war: Meet the military commander who says his soldiers will not rest until every inch of their war torn country is free of Islamist 'terrorists'

‘We won’t stop until Syria is back to normal’

Near the front lines with Islamist-controlled towns where Assad’s troops were besieged just last month, Robert Fisk meets a commander confidently preparing his soldiers for battle
The inside story of how Bill Clinton built a $2bn global foundation may undermine Hillary's chances

The inside story of how Bill Clinton built a $2bn global foundation...

... and how it may undermine Hillary's chances in 2016
12 best olive oils

Extra-virgin, cold-press, early-harvest, ultra-premium: 12 best olive oils

Choosing an olive oil is a surprising minefield. Save yourself the hassle with our handy guide
Sepp Blatter resignation: The beginning of Fifa's long road to reform?

Does Blatter's departure mean Fifa will automatically clean up its act?

Don't bet on it, says Tom Peck
Charles Kennedy: The baby of the House who grew into a Lib Dem giant

The baby of the House who grew into a Lib Dem giant

Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

The harrowing testament of a five-year-old victim of Syria's endless civil war

Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
The future of songwriting: How streaming is changing everything we know about making music

The future of songwriting

How streaming is changing everything we know about making music
William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

Recognition at long last

Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
Beating obesity: The new pacemaker which helps over-eaters

Beating obesity

The new pacemaker which helps over-eaters
9 best women's festival waterproofs

Ready for rain: 9 best women's festival waterproofs

These are the macs to keep your denim dry and your hair frizz-free(ish)
Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

Wiggins worried

Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back